 Model Number |
07 |
Chemical name: (3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one
Molecular formula: C16H15F6N5O
Molecular Weight: 407.32
Merck's diabetes treatment drug Sitagliptin Phosphate, known as commodity JANUVIA (TM), in August 8, 2006 first allowed to market in Mexico and in October 17, 2006 in the United States to obtain FDA approval, is the first approved Listed on the Second-peptide peptidase (DPP-IV) inhibitors
Usage: Type 2 diabetes treatment drug
|
Click to enlarge image
Related Keywords:
Bookmark / Share this page